Structure of an early native-like intermediate of β2-microglobulin amyloidogenesis

Protein Science

Volumn 22, Issue 10, 2013, Pages 1349-1357

  Vanderhaegen, Saskia ^a,b   Fislage, Marcus ^a,b   Domanska, Katarzyna ^a,b   Versées, Wim ^a,b   Pardon, Els ^a,b   Bellotti, Vittorio ^c   Steyaert, Jan ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

2 MIcroglobulin; Dialysis related amyloidosis; Nanobodies; Proline isomerization; Protein conformation; X ray crystallography

Indexed keywords

BETA 2 MICROGLOBULIN; CHAPERONE; MONOMER;

AMYLOIDOGENESIS; AMYLOIDOSIS; ARTICLE; DEVELOPMENT; GENE MUTATION; ISOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; WILD TYPE; X RAY CRYSTALLOGRAPHY;

DIALYSIS-RELATED AMYLOIDOSIS; NANOBODIES; PROLINE ISOMERIZATION; PROTEIN CONFORMATION; X-RAY CRYSTALLOGRAPHY; Β2-MICROGLOBULIN;

AMINO ACID MOTIFS; BETA 2-MICROGLOBULIN; CIRCULAR DICHROISM; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; GLYCINE; HUMANS; MODELS, MOLECULAR; MUTATION, MISSENSE; PROLINE; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; SINGLE-DOMAIN ANTIBODIES;

EID: 84892921640     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2321     Document Type: Article

References (55)

1. Bellotti V, Mangione P, Stoppini M (1999) Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci 55:977-991.
2. Dobson CM (2006) An accidental breach of a proteins natural defenses. Nat Struct Mol Biol 13:295-297.
3. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678-699.
4. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333-366.
5. Domanska K, Vanderhaegen S, Srinivasan V, Pardon E, Dupeux F, Marquez JA, Giorgetti S, Stoppini M, Wyns L, Bellotti V, Steyaert J (2011) Atomic structure of a nanobody-Trapped domain-Swapped dimer of an amyloidogenic b2-Microglobulin variant. Proc Natl Acad Sci USA 108:1314-1319.
6. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512.
7. Radford SE, Gosal WS, Platt GW (2005) Towards an understanding of the structural molecular mechanism of b2-Microglobulin amyloid formation in vitro. Biochim Biophys Acta 1753:51-63.
8. Kozlowski S, Takeshita T, Boehncke W, Takahashi H, Boyd LF, Germain RN, Berzofsky JA, Margulies DH (1991) Excess b2-Microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature 349:74-77.
9. Gejyo F, Odani S, Yamada T, Honma N, Saito H, Suzuki Y, Nakagawa Y, Kobayashi H, Maruyama Y, Hirasawa Y, Suzuki M, Arakawa M (1986). b2-Microglobulin: A new form of amyloid protein associated with chronic hemodialysis. Kidney Int 30:385-390.
10. Brandts JF, Halvorson HR, Brennan M (1975) Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-Trans isomerism of proline residues. Biochemistry 14:4953-4963.
11. Andreotti AH (2003) Native state proline isomerization: An intrinsic molecular switch. Biochemistry 42:9515-9524.
12. Lu KP, Finn G, Lee TH, Nicholson LK (2007) Prolyl cis-Trans isomerization as a molecular timer. Nat Chem Biol 3:619-629.
13. Joseph AP, Srinivasan N, De Brevern AG (2012) Cistrans peptide variations in structurally similar proteins. Amino Acids 43:1369-1381.
14. Jahn TR, Parker MJ, Homans SW, Radford SE (2006) Amyloid formation under physiological conditions proceeds via a native-Like folding intermediate. Nat Struct Mol Biol 13:195-201.
15. Eichner T, Radford SE (2009) A generic mechanism of b2-Microglobulin amyloid assembly at neutral pH involving a specific proline switch. J Mol Biol 386: 1312-1326.
16. Eakin CM, Berman AJ, Miranker AD (2006) A native to amyloidogenic transition regulated by a backbone trigger. Nat Struct Mol Biol 13:202-208.
17. Blaho DV, Miranker AD (2009) Delineating the conformational elements responsible for Cu21-Induced oligomerization of b2-Microglobulin. Biochemistry 48:6610-6617.
18. Myers SL, Jones S, Jahn TR, Morten IJ, Tennent GA, Hewitt AW, Radford SE (2006) A systematic study of the effect of physiological factors on b2-Microglobulin amyloid formation at neutral pH. Biochemistry 45: 2311-2321.
19. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Bajyana Songa E, Bendahman N, Hamers R (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446-448.
20. Muyldermans S, Cambillau C, Wyns L (2001) Recognition of antigens by single-Domain antibody fragments: The superfluous luxury of paired domains. Trends Biochem Sci 26:230-235.
21. Steyaert J, Kobilka BK (2011) Nanobody stabilization of G protein-Coupled receptor conformational states. Curr Opin Struct Biol 21:567-572.
22. Baranova E, Fronzes R, Garcia-Pino A, Van Gerven N, Papaostolou D, P-Ehau-Arnaudet G, Pardon E, Steyaert J, Howorka S, Remaut H (2012) SbsB structure and lattice reconstruction unveil Ca21 triggered S-Layer assembly. Nature 487:119-122.
23. Glabe CG (2004) Conformation-Dependent antibodies target diseases of protein misfolding. Trends Biochem Sci 29:542-547.
24. Dumoulin M, Dobson CM (2004) Probing the origins, diagnosis and treatment of amyloid diseases using antibodies. Biochimie 86:589-600.
25. Khan AR, Baker BM, Ghosh P, Bissison WE, Wiley DC (2000) The structure and stability of an HLAA 0201=octameric tax peptide complex with an empty conserved peptide-N-Terminal binding site. J Immunol 164:6398-6405.
26. Verdone G, Corazza A, Viglino P, Pettirossi F, Giorgetti S, Mangione P, Andreola A, Stoppini M, Bellotti V, Esposito G (2002) The solution structure of human b2- microglobulin reveals the prodromes of its amyloid transition. Protein Sci 11:487-499.
27. Trinh CH, Smith DP, Kalverda AP, Phillips SEV, Radford SE (2002) Crystal structure of monomeric human b2-Microglobulin reveals clues to its amyloidogenic properties. Proc Natl Acad Sci USA 99:9971-9976.
28. Naiki H, Hashimoto N, Suzuki S, Kimura H, Nakakuki K, Gejyo F (1997) Establishment of a kinetic model of dialysis-Related amyloid fibril extension in vitro. Amyloid 4:223-232.
29. Xue W, Homans SW, Radford SE (2008) Systematic analysis of nucleation-Dependent polymerization reveals new insights into the mechanism of amyloid self-Assembly. Proc Natl Acad Sci USA 105:8926-8931.
30. Chi EY, Krishnan S, Kendrick BS, Chang BS, Carpenter JF, Randolph TW (2003) Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-Stimulating factor. Protein Sci 12:903-13.
31. Smith DP, Jones S, Serpell LC, Sunde M, Radford SE (2003) A systematic investigation into the effect of protein destabilisation on b2-Microglobulin amyloid formation. J Mol Biol 330:943-954.
32. Uversky VN, Fink AL (2004) Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim Biophys Acta 1698:131-153.
33. Richardson JS, Richardson DC, Tweedy NB, Gernert KM, Quinn TP, Hecht MH, Erickson BW, Yan Y, McClain RD, Donlan ME, Surles MC (1992) Looking at proteins: Representations, folding, packing, and design. Biophys J 63:1186-1209.
34. Otzen DE, Kristensen O, Oliveberg M (2000) Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: A structural clue to amyloid assembly. Proc Natl Acad Sci USA 97:9907-9912.
35. Richardson JS, Richardson DC (2002) Natural b-Sheet proteins use negative design to avoid edge-To-Edge aggregation. Proc Natl Acad Sci USA 99:2754-2759.
36. Thirumalai D, Klimov DK, Dima RI (2003) Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol 13:146-159.
37. Esposito G, Corazza A, Viglino P, Verdone G, Pettirossi F, Fogolari F, Makek A, Giorgetti S, Mangione P, Stoppini M, Bellotti V (2005) Solution structure of b2- microglobulin and insights into fibrillogenesis. Biochim Biophys Acta 1753:76-84.
38. Valleix S, Gillmore J, Bridoux F, Mangione PP, Dogan A, Nedelec B, Boimard M, Touchard G, Goujon J, Lacombe C, Lozeron P, Adams D, Lacroix C, Maisonobe T, Plant-E-Bordeneuve V, Vrana JA, Theis JD, Giorgetti S, Porcari R, Ricagno S, Bolognesi M, Stoppini M, Delpech M, Pepys MB, Hawkins PN, Bellotti V (2012) Hereditary systemic amyloidosis due to Asp76Asn variant of b2-Microglobulin. N Engl J Med 366:2276-2283.
39. Eichner T, Kalverda AP, Thompson GS, Homans SW, Radford SE (2011) Conformational conversion during amyloid formation at atomic resolution. Mol Cell 41: 161-172.
40. Esposito G, Michelutti R, Verdone G, Viglino P, Hern-Andez H, Robinson CV, Amoresano A, Dal Piaz F, Monti M, Pucci P, Mangione P, Stoppini M, Merlini G, Ferri G, Bellotti V (2000) Removal of the N-Terminal hexapeptide from human b2-Microglobulin facilitates protein aggregation and fibril formation. Protein Sci 9: 831-845.
41. McParland VJ, Kad NM, Kalverda AP, Brown A, Kirwin-Jones P, Hunter MG, Sunde M, Radford SE (2000). Partially unfolded states of b2-Microglobulin and amyloid formation in vitro. Biochemistry 39:8735-8746.
42. Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66:125-132.
43. Karplus PA, Diederichs K (2012) Linking crystallographic model and data quality. Science 25:1030-1033.
44. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40:658-674.
45. Perrakis A, Morris R, Lamzin VS (1999) Automated protein model building combined with iterative structure refinement. Nat Struct Biol 6:458-463.
46. Morris RJ, Zwart PH, Cohen S, Fernandez FJ, Kakaris M, Kirillova O, Vonrhein C, Perrakis A, Lamzin VS (2004) Breaking good resolutions with ARP=wARP. J Synchrotron Radiat 11:56-59.
47. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystollogr D Biol Crystallogr 66:486-501.
48. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structure by the maximum-Likelihood method. Acta Crystallogr D Biol Crystallogr 53:240-255.
49. Winn MD, Isupov MA, Murshudov GN (2001) Use of the TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 57:122-133.
50. Painter J, Merritt EA (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr 62:439-450.
51. Chen VB, Arendall WBIII, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: All-Atom structure validation for macromolecular crystallography. Acta Crystollogr D Biol Crystallogr 66:12-21.
52. Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665-W667.
53. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci USA 98:10037-10041.
54. Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA: A self-Parameterizing force field. Proteins 47: 393-402.
55. Delano W (2002) The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific.